period,total_demand,total_supply,shortage_amount,unsold,shortage_percentage,disrupted_manufacturers,fda_announcement
0,1.2,0.7,0.5,0,0.4166666666666667,[1],The FDA is aware of emerging supply inconsistencies affecting certain pharmaceuticals. We encourage manufacturers and healthcare providers to report any significant disruptions. Coordination efforts are welcomed to maintain market stability.
1,1.5,0.7,0.8,0,0.5333333333333333,[1],The FDA has identified an emerging shortage of [drug name]. We encourage stakeholders to report supply issues and are coordinating efforts to mitigate impacts. Healthcare providers should consider alternative therapies when possible.
